Simple medication check slashes readmission risk for kidney patients?
NCT ID NCT06819527
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a thorough medication review at hospital admission and discharge could reduce mistakes and prevent patients with chronic kidney disease from being readmitted within 90 days. Researchers compared 323 patients who received this extra service to a similar group who got usual care. The goal was to see if careful medication reconciliation leads to fewer errors and better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
medication reconciliation service
What this could lead to
If effective, this approach could become a standard hospital practice to reduce medication mistakes and prevent unnecessary return visits for CKD patients.
What could go wrong
This is a single-center, quasi-experimental study, not a randomized trial, so results may be influenced by unmeasured factors. The intervention is a process change, not a new drug, so impact is modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Abdullah University Hospital and Princess Basma Hospital
Irbid, 22110, Jordan